Time for Well-Powered Controlled Prospective Studies to test a Causal Role for Herpes Viruses in Alzheimer Using Anti-Herpes Drugs.
Twenty-six phase III studies on Alzheimer's Disease (AD) are ongoing or have been completed in 2018. Most of these studies are targeting amyloid-beta, its production, polymerization, and/or multiple interactions. None of the amyloid-beta studies seem to impact positively the clinical outcome of AD patients thus far, no matter the advancement of disease. It is time to consider other hypotheses for the pathogenesis of AD, including the potential role of human herpes viruses (HHV), and especially HHV1 (herpes simplex virus type 1), HHV3 (varicella zoster virus), HHV6A and HHV7. With this Perspective, we review the scientific evidence, and make the case for appropriately powered, prospective, randomized and controlled studies using an anti-HHV drug, to establish a causal role for HHV in AD.